Skip to main content
Join CMKC members for a complimentary virtual event on December 10, 11am ET: CM MythBusters: https://bit.ly/3YXJynA. This is a fantastic opportunity to connect, collaborate, and debunk common myths about continuous manufacturing!
3.145.10.80

Loss-in-Weight Feeding Trials Case Study: Pharmaceutical Formulation

By Engisch, WE; Muzzio, FJ

Published on

Abstract

This article presents a case study of a continuous feeding strategy for five pharmaceutical components (active pharmaceutical ingredient (API), Prosolv HD90, crospovidone, magnesium stearate, and colloidal silicon dioxide), for the purpose of developing a direct compression continuous manufacturing system. Feeding options for each of these five powders were examined. Prosolv HD90 and crospovidone easily resulted in optimal feeding conditions, whereas the remaining powders in the formulation presented some challenges. The API displayed flow issues, leading to clogging of the screen with small openings. Magnesium stearate exhibited shear sensitivity; increasing shear of the powder due to hopper agitation resulted in drifting feeding performance. Colloidal silicon dioxide exhibited electrostatic issues that render most tooling options unsuitable for steady operation. All of these difficulties were resolved using the methods described in this article.

Journal

Journal of Pharmaceutical Innovation. Volume 10, 2015, 56-75

DOI

10.1007/s12247-014-9206-1

Type of publication

Peer-reviewed journal

Affiliations

  • Rutgers State University

Article Classification

Research Article

Classification Areas

  • API
  • Oral Solid Dose
  • Process Control

Tags